- Frontiers in Immunology · 3
- Bone Marrow Transplantation · 2
- Cells · 1
- EBMT1
- Annals of Hematology · 1
- J Translational Medicine · 1
- Exp Hematol & Oncol · 1
- J Immunother Cancer · 1
- Regenerative Therapy · 1
- Frontiers in Medicine · 1
- ASTCT · 1
CAR-T細胞治療原理1 份
- Tracing the development of CAR-T cell design: from concept to next-generation platforms
CAR-T適應症與病人篩選1 份
- Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations
白血球分離術1 份
- Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL
細胞製備與品質管制1 份
- A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors
橋接治療與淋巴清除化療1 份
- Lymphodepletion chemotherapy in CAR-T cell therapy in lymphoma
CAR-T輸注流程1 份
- The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy
細胞激素釋放症候群分級與處置1 份
- Latest updates on pathogenesis and management for CRS, neurotoxicity, and HLH related to CAR-T
免疫效應細胞相關神經毒性1 份
- ICANS following CAR T-cell therapy: a review of recent advances
腫瘤浸潤淋巴球與自然殺手細胞治療1 份
- Recent advances in adoptive cell therapy for cancer immunotherapy(TIL/NK/CAR-NK)
樹突細胞疫苗1 份
- Research progress on dendritic cell vaccines in cancer immunotherapy
細胞治療長期追蹤1 份
- Data-informed optimization of CAR T-cell therapy long-term follow-up (position article and guidelines)
細胞治療法規與特管辦法1 份
- Pathing the way from regulatory approval to market access for gene therapy products (US/EU5/Japan/China)
再生醫療品質與優良操作規範1 份
- Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products
輸注後感染與B細胞缺乏處置1 份
- ASTCT Best Practice Considerations: Infection Prevention and Management After CAR T Cell Therapy
使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入
